| 000 | 01729 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515173236.0 | ||
| 264 | 0 | _c20090723 | |
| 008 | 200907s 0 0 eng d | ||
| 022 | _a1873-1708 | ||
| 024 | 7 |
_a10.1016/j.reprotox.2009.02.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGersak, Ksenija | |
| 245 | 0 | 0 |
_aAngiotensin II receptor blockers in pregnancy: a report of five cases. _h[electronic resource] |
| 260 |
_bReproductive toxicology (Elmsford, N.Y.) _cJul 2009 |
||
| 300 |
_a109-12 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAbnormalities, Drug-Induced _xetiology |
| 650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xadministration & dosage |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBiphenyl Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGestational Age |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aIrbesartan |
| 650 | 0 | 4 |
_aKidney Diseases _xchemically induced |
| 650 | 0 | 4 |
_aLosartan _xadministration & dosage |
| 650 | 0 | 4 |
_aOligohydramnios _xchemically induced |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPregnancy Complications, Cardiovascular _xdrug therapy |
| 650 | 0 | 4 |
_aPremature Birth _xchemically induced |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSlovenia |
| 650 | 0 | 4 |
_aTetrazoles _xadministration & dosage |
| 700 | 1 | _aCvijic, Marta | |
| 700 | 1 | _aCerar, Lilijana Kornhauser | |
| 773 | 0 |
_tReproductive toxicology (Elmsford, N.Y.) _gvol. 28 _gno. 1 _gp. 109-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.reprotox.2009.02.004 _zAvailable from publisher's website |
| 999 |
_c18915546 _d18915546 |
||